BeOne Medicines
ONC
#780
Rank
C$43.27 B
Marketcap
C$417.13
Share price
-3.77%
Change (1 day)
35.67%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: C$43.27 Billion

As of May 2026 BeOne Medicines has a market cap of C$43.27 Billion. This makes BeOne Medicines the world's 780th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026C$43.27 B-8.58%
2025C$47.34 B61.08%
2024C$29.38 B12.4%
2023C$26.14 B-24.24%
2022C$34.51 B-2.56%
2021C$35.41 B17.36%
2020C$30.17 B126.15%
2019C$13.34 B17.22%
2018C$11.38 B103.46%
2017C$5.59 B245.63%
2016C$1.61 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of BeOne Medicines was reported to be:

C$48.19 Billion
by Nasdaq info icon info icon
C$44.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
C$1.13 B-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C$28.62 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA